As of May 27
| +0.01 / +0.98%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +482.52% increase from the last price of 1.03.
The current consensus among 1 polled investment analysts is to Buy stock in X T L Biopharmaceuticals Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.